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The shared cytokine receptor gp130 signals as a
homodimer or heterodimer through activation of
Janus kinases (Jaks) associated with the receptor
intracellular domains. Here, we reconstitute, in parts
and whole, the full-length gp130 homodimer in com-
plex with the cytokine interleukin-6 (IL-6), its alpha
receptor (IL-6Ra) and Jak1, for electron microscopy
imaging. We find that the full-length gp130 homo-
dimer complex has intimate interactions between
the trans- and juxtamembrane segments of the two
receptors, appearing to form a continuous connec-
tion between the extra- and intracellular regions. 2D
averages and 3D reconstructions of full-length Jak1
reveal a three lobed structure comprising FERM-
SH2, pseudokinase, and kinase modules possessing
extensive intersegmental flexibility that likely facili-
tates allosteric activation. Single-particle imaging
of the gp130/IL-6/IL-6Ra/Jak1 holocomplex shows
Jak1 associated with the membrane proximal intra-
cellular regions of gp130, abutting the would-be
inner leaflet of the cell membrane. Jak1 association
with gp130 is enhanced by the presence of a mem-
brane environment.
INTRODUCTION
Cytokine-induced homo- or heterodimerization of cell surface
receptors is a ubiquitous signaling paradigm in higher eukary-
otes (Stroud and Wells, 2004; Wang et al., 2009). Cytokines of
the four helix bundle family are required for the growth and differ-
entiation of nearly all cell types, but are particularly important for
regulation of the immune and hematopoietic systems. Activation
of signaling involves homo- or heterodimerization of two recep-
tors by a single cytokine molecule, as first illustrated by HumanStructure 19,Growth Hormone (HGH) in complex with its receptor (HGH-R)
(de Vos et al., 1992). This dimerization event initiates activation
of Janus kinases (Jaks) that are bound to the intracellular
domains of the receptors (Ihle, 1995). The active kinases
then phosphorylate the C-terminal intracellular tails of the recep-
tors on specific tyrosine residues, creating binding sites for
pathway-associated signaling molecules such as STAT (signal
transducer and activator of transcription) transcription factors
which, upon phosphorylation by the active Jaks, translocate to
the nucleus where they activate transcription of cytokine-
responsive genes (Leonard and O’Shea, 1998).
Gp130 serves as a shared signaling receptor for at least eight
different cytokines, including IL-6, IL-11, IL-27, Leukemia Inhib-
itory Factor (LIF), Oncostatin-M (OSM), Ciliary Neurotrophic
Factor (CNTF), Cardiotrophin-1 (CT-1), and Cardiotrophin-like-
cytokine (CLC) (Bravo and Heath, 2000; Wang et al., 2009).
Gp130 has evolved a remarkable set of structural characteristics
to facilitate shared signaling. First, gp130 has evolved cross-
reactive cytokine binding sites that are structurally ideal for
engaging a highly varied set of cytokines either alone (LIF,
OSM) or with associated alpha receptor subunits (IL-6, IL-11,
CNTF, CT-1, CLC) (Boulanger et al., 2003a; Boulanger and Gar-
cia, 2004). Second, gp130 can homodimerize or heterodimerize
with a second gp130 family receptor (LIFR, OSMR, TCCR)
depending on the cytokine encountered (Heinrich et al., 2003).
Homodimerization of gp130, which occurs in response to the
cytokines IL-6 and IL-11, occurs in a three step fashion, with
the cytokine first binding to the ligand-specific alpha receptor
(site 1), followed by binding to gp130 to form the signaling-
competent hexamer (Boulanger et al., 2003b; Chow et al.,
2001) that comprises the membrane-distal ‘‘headpiece’’ and
membrane-proximal ‘‘legs’’ (Figure 1A). An electron microscopy
(EM) study of the complete extracellular domains of gp130
bound to IL6/IL6-Ra indicated a convergence of the membrane
proximal D6 ‘‘leg’’ domains of gp130 (Skiniotis et al., 2005).
This finding was supported by a cryoelectron microscopic study
of the IL-11/IL-11Ra/gp130 complex, where the legs also ap-
peared to converge in a ring-like shape (Matadeen et al., 2007).
A subsequent EM study on the full-length gp130/LIF-R/CNTF45–55, January 12, 2011 ª2011 Elsevier Ltd All rights reserved 45
Figure 1. Assembly and Purification of the
Full-Length gp130/IL-6/IL-6Ra Complex
(A) Components of the gp130/IL-6/IL-6Ra com-
plex in pre- and postassembly state. A surface
rendering of the structure of the signaling hexamer
is shown on top. IgD denotes Ig-like domain, CHR
denotes cytokine-binding homology region, and
FnIII denotes Fibronectin-type III domain.
(B) Purification of the gp130/ IL6/IL6Ra complex
by size exclusion chromatography.
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Imaging Jak1 and Transmembrane Cytokine Receptorscomplex, containing the TM segments and intracellular domains
(ICDs), revealed a surprisingly intimate interaction between
the extracellular juxtamembrane domains of gp130 and LIF-R
(Skiniotis et al., 2008). Finally, a recent crystal structure of a
complete, but unliganded, gp130 extracellular domain showed
that, consistent with the EM studies, the gp130 legs are kinked
at the D4-D5 boundary, and as a result would bend inward
toward one another within the dimeric complex (Xu et al., 2010).
A critical piece of the puzzle to understand cytokine receptor
signaling involves the Jak/Tyk family of intracellular kinases,
which have remained enigmatic structurally (Leonard and
O’Shea, 1998; Schindler et al., 2007). The Jak/Tyk family
consists of four members, Jak1, Jak2, Jak3, and Tyk2, that are
associated with cytokine receptors through a small membrane-46 Structure 19, 45–55, January 12, 2011 ª2011 Elsevier Ltd All rightE
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‘‘Box 1/Box 2’’ (Haan et al., 2006; Mura-
kami et al., 1991). The Jaks are 1200
amino acid proteins that are subdivided
by sequence into seven Janus homology
regions (JH1-7) which fold into four
distinct domains (Haan et al., 2006). The
N terminus consists of a FERM domain,
which mediates the interaction with cyto-
kine receptors, followed by an SH2-like
domain and a pseudokinase domain
that lacks catalytic activity, and finally
the C terminus is the active tyrosine
kinase domain (KD). Several publications
have suggested that Jak activation is
regulated through interdomain com-
munication, such as between the FERM
and KD, requiring conformational change
during signaling (Zhou et al., 2001).
Further, disease-related mutations in
Jaks have been speculated to interfere
with the ability of Jak to undergo normal
allosteric regulation (Funakoshi-Tago
et al., 2008; Zhou et al., 2001). However,
although several isolated KD structures
have been reported (Boggon et al.,
2005; Chrencik et al., 2010; Lucet et al.,
2006), little is known about the structure
of intact Jak family members.
In this study, we capitalize on the char-
acteristic shape of the ‘‘tall’’ gp130 extra-
cellular regions to visualize the full-length
receptor holocomplex by single particleM. We reconstitute and image a receptor signaling complex
cluding IL-6, IL-6Ra, gp130, and Jak1, both in isolation, and
complex with each other. The EM images indicate that
e full-length gp130/IL-6/IL-6Ra ternary complex forms a well-
efined, structurally stabilized assembly with the juxtamem-
rane and transmembrane domains in intimate contact upon
gand binding. Projection averages and reconstructions of
ak1 show it to be a three-lobed molecule with conformational
exibility that could, in principle, facilitate interdomain communi-
ation. The holocomplex images suggest that homodimerization
f gp130 by IL-6 locks the extracellular/transmembrane domains
f gp130 together into continuous unit that can sensitively
ansduce a conformational signal through the plasma mem-
rane to Jaks that are bound at the extreme juxtamembrane
Figure 2. 2D EM Averages of the Full-
Length gp130/IL-6/IL-6Ra Complex
(A) Raw image of negatively stained full-length
gp130/IL-6/IL-6Ra complexes. Representative
particles are boxed in yellow.
(B) 2D class averages of the gp130/hyper IL-6
complex produced by the classification of 6070
particles.
(C) Comparison of a 2D class average to a model
based on the gp130/IL-6Ra/IL-6 complex (left).
The cartoon on the right shows the domain organi-
zation of the gp130/ IL-6Ra/IL-6 complex. Lines
overlaid on the 2D average trace the chains of
the receptors and denote the location of the IL-6
cytokine.
Scale bars in (A) and (B) and (C) correspond to 40
and 10 nm, respectively.
See also Figure S1.
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Imaging Jak1 and Transmembrane Cytokine Receptorsregions of the intracellular domains, likely interacting with the
inner leaflet of the cell membrane.
RESULTS
Imaging the gp130/IL-6/IL-6Ra Transmembrane
Complex
We took advantage of the highly characteristic and extended
structure of gp130, which as a ‘‘tall’’ receptor has six extracel-
lular domains, compared with two or three for most cytokine
receptors, to attempt EM imaging of the full-length receptor
(Figure 1A). The extracellular complex structure is a roughly
triangular assembly containing the membrane-distal ligand
binding ‘‘headpiece’’ and membrane-proximal ‘‘legs,’’ and these
obvious features serve as clear fiducial landmarks for particle
identification on EM grids. As a prerequisite to reconstituting
a complete IL-6/IL-6Ra/gp130/Jak1 quaternary signaling com-
plex, we first purified and characterized the full-length ternary
complex between IL-6, IL-6Ra, and gp130 in order to produce
comparison images of the receptor complex with and without
Jak1 included.
We expressed full-length gp130 in insect cells, with a
C-terminal antibody epitope tag (EYMPME) and solubilizedStructure 19, 45–55, January 12, 201the receptor in the detergent n-do-
decyl-b,D-maltoside (DDM). Gp130 was
then captured from the detergent
solubilized membranes by a Glu-Glu
antibody affinity column and competi-
tively eluted with soluble peptide. The
eluate was then incubated with an
excess of soluble IL-6/IL-6Ra fusion pro-
tein (also termed ‘‘hyper-IL6’’; Fischer
et al., 1997) to form the dimerized
ternary complex (i.e., the hexamer), and
further purified by size exclusion chro-
matography (Figure 1B). The complex
was very stable and eluted from the
column as a single peak of 400 kDa,
which is the approximate size of two
receptors (2 3 110 kDa) and twohyper-IL-6 molecules (2 3 55 kDa), allowing 90 kDa for the
detergent micelle.
We then employed EM to visualize the complexes embedded
in negative stain, which revealed monodisperse particles of
similar size and shape (Figure 2A). Classification of 6070 parti-
cles (from 56 images taken on film) into 15 classes produced
class averages that showed a dominant preferred particle orien-
tation on the carbon support (see Figure S1 available online).
As we have previously observed in the case of the extracellular
gp130 complex (Skiniotis et al., 2005), the class averages of
the full-length gp130 complex reveal a characteristic pseudo-
two-fold symmetric particle, in which the gp130 leg domains
(D4-D6) project from the cytokine binding headpiece containing
IL-6 and IL-6Ra, and subsequently bend toward each other
before joining at the their C-terminal tips at the level of the TM
segments (Figures 2B and 2C). Strikingly, in contrast to the leg
flexibility observed in the complex that contained only the extra-
cellular domains of gp130 (Skiniotis et al., 2005), the class aver-
ages of the full-length gp130 complex containing TM segments
indicate a conformationally rigid particle with uniform closure
of the gp130 membrane-proximal domains (Figure 5, compare
top and middle panels). The 2D averages here show homoge-
nous leg positioning, with the D6 and transmembrane domains1 ª2011 Elsevier Ltd All rights reserved 47
Figure 3. Purification and 2D Projections of Recombinant Human Jak1
(A) Jak1 was expressed using the BacMam system, and purified from 293S cell lysate via a C-terminal 8-Histidine tag using Ni-affinity column.
(B) Second step, streptactin-affinity purification of Jak1 via its N-terminal Strep-tag.
(C) Silver-stained gel of Streptactin-purified Jak1 after a Superose 6 size exclusion chromatography step. These fractions were selected for negative stain EM.
See Figure S2.
(D) Representative 2D class averages of purified Jak1 obtained from the classification of 9258 particles. The marked classes were used independently for 3D
reconstructions.
See also Figures S3–S5.
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Imaging Jak1 and Transmembrane Cytokine Receptorsclosely apposed. The presence of the TM segments in the
complexmay possibly stabilize the leg closure of gp130, as cyto-
kine receptor TM helices have been proposed to self-associate
within the membrane (Constantinescu et al., 2001; Kubatzky
et al., 2001). Below the TM regions, little density was visible, indi-
cating the intracellular domains of the gp130 homodimeric
complex are loosely structured as seen in the gp130/LIFR heter-
odimeric complex (Skiniotis et al., 2008).
Purification and Imaging of Jak1
To generate sufficient quantities of Jak1 for imaging studies, we
used the BacMam system and 293S cells (Figure 3; Dukkipati
et al., 2008). Prior efforts to produce a variety of different full-
length Jak molecules in insect cells resulted in aggregated and
inactive material. The material from 293S cells is soluble,
although it is not amenable to high protein concentrations, and
solubility is enhanced by the presence of detergent (0.01%
DDM). We utilized a three step purification scheme to purify
Jak1 to >98% purity (Figures 3A–3C). Jak1 was first purified
via a C-terminal 8-Histidine tag from 4 liters of 293S cell lysate
using Nickel-agarose (Figure 3A), followed by Streptactin purifi-
cation via an N-terminal Strep-tag (Figure 3B). The protein was
then purified by size exclusion chromatography on Superose 6
to generate monodisperse Jak1 for EM imaging (Figure 3C).
While the gel filtration elution peak was broad, a significant frac-
tion of the material eluted at a position expected for monomeric
Jak1. Additionally, the recombinant Jak1 we purified from
mammalian cells was active at phosporylating the gp130 intra-
cellular domain in kinase assays (Figure S2).48 Structure 19, 45–55, January 12, 2011 ª2011 Elsevier Ltd All rightWe again employed negative stain EM to visualize our prepa-
rations of Jak1 (Figure 3D). Raw images of Jak1 indicated
a monodisperse particle population, albeit with a high degree
of conformational variability (Figure S3). To analyze these con-
formers we interactively selected 24,356 particle pairs and
used image classification to select the most consistent 9258
particles (Figure S4; see Experimental Procedures). After classi-
fication of the 9258 particles from the images of the untilted
specimens into 50 classes (Figure S5), the resulting 2D class
averages of Jak1 (representative 2D averages shown in Fig-
ure 3D) confirmed our suspicion of a highly flexible particle
ranging from an extended to a compact conformation. In the
class averages we can discern three main lobe densities, two
in constant close proximity, and a third more globular, larger
one in variable positions.
3D Reconstruction of Jak1
To gain further insight to the conformations presented by Jak1,
and considering the high level of conformational variability
observed, we used the corresponding particles selected from
images of the tilted specimens to calculate separate 3D recon-
structions for individual classes (containing from 446 to 1050
particles) produced by 2D classification (Figure 3D; Figure S5).
While there are many classes evident, we focused our approach
on three well-defined classes that exemplify intermediates in
a transition from a fully extended to a compact conformation,
as shown in Figure 4 (top panel-open to bottom panel-closed).
3D reconstructions were initially calculated by back-projection
according to the random conical tilt method (Radermachers reserved
Figure 4. 3D Reconstructions andModeling
of Full-Length Human Jak1
3D reconstructions of Jak1 are based on individual
classes obtained from 2D classification of untilted
specimen projections (marked in Figure 3D and
Figure S6). From the top to the bottom of the
panel Jak1 particles transition from open to
closed conformations. The FERM (green), SH2-
like (cyan), pseudokinase (yellow), and kinase
(red) domains of Jak1 were modeled into the EM
densities. The orientations of the reconstructions
in the left column of the panel are viewing the parti-
cles ‘‘face-on’’ the grid (as shown in the 2D class
averages of Figure 3D), while the orientations to
the right are rotated 90, reflecting the flatness of
the surface on which Jak1 is lying.
See also Figures S5 and S6.
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Imaging Jak1 and Transmembrane Cytokine Receptorset al., 1987) and further refined after the inclusion of 0 particle
projections. The resulting 3D models at a resolution of 35 A˚
(as judged by Fourier shell correlation) (Figure S6) reveal a highly
asymmetric molecule displaying three major lobes (Figure 4).
As also indicated in the 2D class averages (Figure 3D), two of
the major lobes are always in close proximity, in what appear
to be extended ‘‘longitudinal’’ interactions. In contrast, the third
lobe appears as an individually larger, more globular domain that
is loosely connected to the first two modules, thereby adopting
variable positions with respect to the other two lobes. Interest-
ingly, with the exception of the fully extended conformation
(‘‘open’’), all reconstructions display an additional minor lobe,
or ‘‘bump,’’ which projects between the globular mobile and
the two stable lobes, that is most likely the SH2 domain (indi-
cated by arrows in Figure 4).
In order to interpret the densities revealed in our reconstruc-
tions we manually fit models of appropriate domains from avail-
able crystal structures into the density maps. To model the
kinase and pseudokinase domains, we used two copies of the
atomic resolution structure of the Jak1 kinase domain (PDB ID:
3EYH) (Chrencik et al., 2010). We used homologous crystal
structures for the Focal Adhesion Kinase FERM domain (PDB
ID: 2AL6) (Ceccarelli et al., 2006) and the Src SH2 domain
(PDB ID: 1IJR) (Kawahata et al., 2001). Sequence comparisons
indicate that the interdomain linker connecting the FERM-
SH2 module with the pseudokinase module is approximatelyStructure 19, 45–55, January 12, 20120 amino acids long. Thus we reasoned
that the larger globular lobe, loosely con-
nected at one end of the EM density
should correspond to the FERM domain,
which appears to fit well in that position
(Figure 4). In a next step, we modeled
the SH2 domain at the border region
between the FERM domain and two
stable major lobes, thereby occupying
the minor lobe shown in our 3D recon-
structions. Subsequently, we docked
the pseudokinase domain within the
middle major lobe, which is immediately
adjacent to the FERM-SH2 module, fol-
lowed by the C-terminal kinase domain(KD). The 3D maps lack sufficient resolution to propose specific
interactions between the individual domains of Jak1. However,
our density maps and modeling argue that the FERM-SH2
module adopts variable conformations in relation to the pseudo-
kinase-kinase module, and this is consistent with sequence
analysis that indicates a longer linker between the FERM-SH2
and pseudokinase domains. In the compact Jak1 conformation,
the close proximity of the FERM-SH2 module to the catalytic KD
supports the possibility of a direct interaction as has been sug-
gested by earlier biochemical studies (Funakoshi-Tago et al.,
2008; Zhou et al., 2001), and analogous to that seen for Focal
Adhesion Kinase (discussed later) (Lietha et al., 2007).
Preparation and Imaging of the gp130/IL-6/IL-6Ra/Jak1
Complex
To prepare the quaternary gp130/IL-6/IL-6Ra/Jak1 complex,
purifications of the ternary gp130/IL-6/IL-6Ra complex and
Jak1 were carried out concurrently. The gp130 complex was
mixed with Jak1 purified from Streptactin, incubated overnight,
and further purified by either anion exchange (Mono-Q) (Fig-
ure 5A) or size exclusion chromatography. Jak1 alone does not
adhere strongly to mono-Q, but co-elutes as a complex with
the receptor, although there is some dissociation during purifica-
tion since the interaction does not appear to be high affinity.
Raw EM images of our gp130/IL-6/IL-6Ra/Jak1 complex prepa-
rations in negative stain showed a significant fraction of bulkier1 ª2011 Elsevier Ltd All rights reserved 49
Figure 5. Purification and EM Imaging of the
gp130/IL-6/IL-6Ra/Jak1 Complex
(A) Anion-exchange chromatography of the
gp130/Jak1 complex. Fractions from the Mono-
Q column were analyzed by SDS-PAGE gel and
western blot with anti-GluGlu (gp130) and anti-
Jak1 antibodies (panel underneath). Since two
different antibodies were used to detect gp130
(Anti-GluGlu) and Jak1 (Anti-Jak1) the relative
ratios of gp130/Jak1 cannot be derived from this
experiment. The anti-GluGlu mAb appears to be
more sensitive than anti-Jak1.
(B) Comparison of representative 2D averages for
the soluble gp130/IL-6/IL-6Ra extracellular
complex (top three panels), full-length gp130/IL-
6/IL-6Ra (middle panels, as shown in Figure 2B),
and the gp130/IL-6/IL-6Ra/Jak1 complex (bottom
three panels). Schematics for each complex are
shown in the far right column. The extra fuzzy
density in the Jak1 loaded complexes is apparent
by comparison to the non-loaded complexes.
See also Figures S7 and S8.
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Imaging Jak1 and Transmembrane Cytokine Receptorsparticles when compared to full-length receptor in the absence
of Jak1 (Figure S7). Wewere able to easily discern the character-
istic side views of the extracellular domains and headpiece, as
seen in the soluble and full-length receptor complex EM images
not containing Jak1, with significant additional mass following
the membrane proximal FNIII legs and TM regions (Figure 5B,
bottom row). We selected 14,008 particles from 224 images
taken on imaging plates, of which 3975 particles (see Materials
and Methods) were used for the final classification into 30
classes (Figure S8). Most of the resulting class averages show
the clear pseudo-two-fold symmetric densities representing
the extracellular regions of the receptor complex (representative
class averages shown in Figure 5B, bottom panels). Directly
below the transmembrane level we observe additional density
that can only represent the bound Jak1. In fact, direct compar-
ison of the ‘‘unloaded’’ gp130/IL-6/IL-6Ra ternary complex to
that ‘‘loaded’’ with Jak1 clearly shows its position (compare Fig-
ure 5B middle and bottom rows). However, the Jak1 densities
appear ‘‘fuzzy’’ and are not well resolved. This is likely due to50 Structure 19, 45–55, January 12, 2011 ª2011 Elsevier Ltd All rights
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tions, and also variable orientations of
Jak1 on the carbon support. This confor-
mational mixture is probably also ampli-
fied by the flexible nature of the gp130
intracellular domains to which Jak1 is
bound. Nevertheless, Jak1 appears to
bind near the base of the TM region, at
the extreme membrane proximal region
of the gp130 ICD, where its binding site
has been mapped (Haan et al., 2002).
Given the apparent ‘‘free swinging’’ of
the Jak1/ICD module underneath the
TM segment in the detergent-solubilized
receptor complex, and the proximity
of the inner leaflet of the membrane
bilayer in the cell, we were curious if the
addition of a bilayer environment mighttabilize the Jak1 interaction. Therefore we reconstituted
p130/IL-6/IL-6Ra complexes in nanodiscs, which provide
bilayer surrounding the TM region (Figure 6). The nanodisc
constitution was highly efficient for the gp130 complex using
e MSP-1 protein and lipid to displace the detergent micelle.
e were able to purify the ternary complex by gel filtration in
e absence of detergent. We then added purified recombinant
ak1 to the gp130/IL-6/IL-6Ra nanodisc, and subjected the
ixture to gel filtration (Figure 6). We found that the association
f Jak1 with gp130 was far more stable and efficient than in
etergent micelles (Figure 5), and the resultant holocomplex
ould be purified in nearly a stoichiometric ratio, with little Jak1
issociation.
ISCUSSION
ur mechanistic understanding of communication between
ytokine recognition and intracellular Jak/Tyk activation is poor
ompared to systems such as receptor Tyrosine Kinase’s
Figure 6. Reconstitution of the gp130/IL-6/
IL-6Ra/Jak1 Complex in Lipid Nanodiscs
(A) The quaternary gp130/IL-6/IL-6Ra/Jak1 com-
plex was prepared and incorporated into lipid
‘‘nanodiscs’’ comprising DPPC and the MSP1
scaffold protein, and purified by gel filtration
chromatography (Superose 6) in the absence of
detergent.
(B) Jak1 was then added to the nanodiscs contain-
ing gp130/ gp130/IL-6/IL-6Ra and again applied
to a Superose 6 size exclusion column. Since
full-length Jak1 and gp130 comigrate on SDS-
PAGE, peak fractions were subjected to SDS-
PAGE and Coomassie staining (top panel) and
western blotting with an anti-Jak1 antibody
(bottom panel) in order to confirm the presence
of both components. Higher resolution SDS-
PAGE and Coomassie confirms that both proteins
are present in roughly equal amounts.
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Imaging Jak1 and Transmembrane Cytokine Receptors(RTK’s), and Death receptors. The principal challenges to
making progress on this problem have been the historic recalci-
trance of Jak expression, and the difficulties posed by intact
single-pass TM receptors for structural studies. Our strategy
was to produce full-length Jak1 for EM analysis both alone and
in complex with full-length gp130, and this has enabled us to
report the first structural snapshots of Jak1, as well as of a fully
‘‘loaded’’ transmembrane receptor complex. While the mecha-
nistic insight that can be gained from our studies is limited, the
results we show here are informative on several levels. Our
choice of gp130 was driven by its very characteristic extracel-
lular structure by single-particle EM, which allows us to rapidly
identify and orient particles. These studies demonstrate imaging
of the cytokine receptor holocomplex is technically feasible,
and that higher resolution imaging methodologies combinedStructure 19, 45–55, January 12, 201with nanodisc stabilization could lead to
deeper mechanistic insights.
Imaging of the gp130/IL-6/IL-6Ra
Complex
Two previous single-particle EMstudies of
gp130 complexes with IL-6 and IL-11,
respectively, included only the extracel-
lular domains of gp130 (Matadeen et al.,
2007; Skiniotis et al., 2005). In the gp130/
IL-6/IL-6Ra study, the majority of particles
showed the gp130 leg domains together
at the level of themembrane, but a number
of other ‘‘open’’ conformations were
observed, indicating that the leg domains
were not necessarily holding the trans-
membrane domains together. In the
IL-11/IL-11Ra/gp130 ectodomain com-
plex, normal-mode analysis of the ring-
like structure indicated a high degree of
conformational flexibility in the leg regions
thatwas speculated to facilitate rearrange-
ment during signaling. In the current study,
we observe that when the transmembraneand intracellular domains are included, the gp130 leg domains
uniformly converge at the level of the membrane, and form an
apparently continuous, possibly rigidified unit together with the
transmembranesegments. This interaction isconsistentwith func-
tional data suggesting critical interactions between themembrane
proximal domains of gp130,where antagonistic antibodiesmap to
the D4-D6 region of gp130 (Kurth et al., 2000). Association of the
TM regions is also in accord with studies on EPO and Prolactin
receptors showing the TM helix packing interactions within
cytokine receptor dimers may be prevalent (Constantinescu
et al., 2001; Kubatzky et al., 2001). Our prior EM imaging studies
of the heterocomplex of full-length gp130 and LIF-R in complex
with CNTF/CNTF-Ra, also indicated that the leg and TM domains
were intimately associated upon ligand binding (Skiniotis et al.,
2008).1 ª2011 Elsevier Ltd All rights reserved 51
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Imaging Jak1 and Transmembrane Cytokine ReceptorsThe gp130 leg domains are ‘‘kinked’’ near the D4-D5-D6
boundaries, forcing the trajectory of the legs toward the center
of the complex, enabling the juxtamembrane and transmem-
brane domains to be in close proximity. Indeed, a kink is also
observed in this region of the D5 domain of gp130 in the
gp130/LIFR/CNTF/CNTF-Ra complex (Skiniotis et al., 2008),
and an acute bend between the D4 and D5 domains is observed
in the crystal structure of the entire gp130 extracellular domain
(Xu et al., 2010). Thus, the compendium of gp130 structures,
both crystallographic and EM, suggest that the gp130 legs are
bent, and in intimate association within the active signaling
complex. Although we cannot visualize the TM interactions in
detail at the resolution of the EM analysis, the structural evidence
suggests that the close association of the membrane proximal
regions of the legs is most likely assisted by packing interactions
between the TM helices within the dimer, forming a continuous
unit between the extracellular juxtamembrane regions and the
TM. Thus, this possible packing between the TM helices of
cytokine receptor dimers may be a general means of rigidifying
the linkage between extracellular cytokine recognition and
intracellular signaling. Such a rod-like unit would facilitate the
transmission of subtle receptor positional differences to the
intracellular signaling components by propagating, rather than
absorbing extracellular torque. A similar model has been previ-
ously proposed based on structure-function studies of the
EPO receptor (Seubert et al., 2003).
Imaging of Jak1
Our current structural knowledge of the Jak/Tyk family is limited
to the obvious homologies of individual domains to known folds,
such as the FERM, SH2 and pseudokinase domains, and crystal
structures of several Jak KD’s, including Jak1. But it is important
to structurally characterize a full-length Jak given the apparent
interdomain communication required for activation. 2D class
averages and 3D reconstructions of full-length Jak1 indicate
that the four major subdomains fold into three modules: (1) the
larger FERMmodule, (2) an extended pseudo-kinase and kinase
module, and (3) a module consisting of a smaller domain
between the lobes that is likely the SH2-like domain (Figure 4).
It is clear from our analysis that the Jak1 subdomains are highly
flexible with respect to one another, and can exist in wide array
conformations ranging from open to closed. Our results also
suggest that the kinase and pseudokinase subdomains are
closely associated with one another, forming a rather continuous
bi-lobed module. This configuration differs from the JH1-JH2
domain relationship predicted from a homology modeling study
of Jak2 that was based on the FGF receptor kinase dimer struc-
ture (Lindauer et al., 2001). Several previous studies have sug-
gested that regulation of the C-terminal KD takes place through
its interactions with the N-terminal FERM domain, which would
necessitate a compact state of Jak (Saharinen and Silvennoinen,
2002; Zhou et al., 2001). Coexpression of the isolated FERM
domain with the isolated KD of Jak1, and deletion of the pseudo-
kinase domain in Jak2 and Jak3, enhances KD activity. These
findings suggest that: (1) the ‘‘active’’ form of Jak requires close
proximity between the N- and C-terminal domains, and (2) a role
of the pseudokinase domain may be to sterically interfere with
Jak KD activation until receptor dimerization initiates a con-
formational change in Jak. Interestingly, in the compact Jak152 Structure 19, 45–55, January 12, 2011 ª2011 Elsevier Ltd All rightconformation we see by EM, the FERM and SH2 domains
come in very close proximity to the catalytically active C-terminal
KD, consistent with the biochemical studies (Zhou et al., 2001).
Therefore, the built-in flexibility of Jak1 may facilitate regulation
of KD activity by allowing Jak1 to shuttle between open and
closed states. It was speculated recently that cytosolic Jak2
may be ‘‘locked’’ into an inactive compact state until its FERM
domain engages the receptor (Funakoshi-Tago et al., 2008).
Contrary to this model, our ‘‘free-floating’’ Jak1 reveals a highly
diverse conformational ensemble relatively evenly dispersed
between open and closed states, and partial open/closed states,
that does not appear to be locked into a particular structure.
However, we cannot say whether, or if, the open or closed
conformations correspond to active or inactive Jak1. In order
to address this, we have attempted to lock Jak1 into a compact
state using linkers and other engineering approaches, but have
so far been unsuccessful.
Focal Adhesion Kinase (FAK) has structural analogies to Jak/
Tyk kinases, since FAK possesses an N-terminal FERM domain
and a C-terminal KD. In the structure of autoinhibited FAK, the
FERM and KD are in direct contact such that the FERM prevents
access to the KD phosphorylation sites, whereas in the activated
state, the FERM interaction is relieved (Lietha et al., 2007). Like
FAK, Jak1 also possesses an N-terminal FERM and C-terminal
KD that we see by EM exist in highly variable positions relative
to one another, either in contact in the compact conformation,
or far apart in the open conformation. The analogy to FAK
suggests that the compact Jak1 conformation may represent
an ‘‘inactive’’ conformation, in which the KD is autoinhibited by
FERM interactions. However, unlike FAK, in Jak1 the FERM/KD
interaction does not appear to be stable in solution in that the
particles do not preferentially segregate into a close state. There
is also the further consideration that FAK is a freely diffusing
molecule within the cytosol, whereas Jak/Tyk proteins are
primarily associated with cytokine receptors, which almost
certainly influence Jak conformation. Thus, the receptor-bound
form is, indeed, a more physiologically relevant state in which
to image Jak, and this is where our efforts are directed.
The gp130/IL-6/IL-6Ra/Jak1 Complex
We prepared gp130/IL-6/IL-6Ra ternary complexes both in
detergent micelles as well as in lipid ‘‘nanodiscs’’ that reconsti-
tute a more physiological environment for transmembrane
helices. Holocomplexes in detergent micelles were subjected
to negative staining and EM imaging. The characteristic two-
fold symmetric extracellular domains of gp130/IL-6/IL-6Ra are
well resolved in the 2D averages. Below the TM region, a fuzzy
density is observed that likely corresponds to bound Jak1 mole-
cules, but the density cannot be fit with any Jak1 domains given
its smeared character.
Imaging of the holocomplex denotes a proof-of-concept tech-
nical benchmark that requires substantial improvement before
detailed structural conclusions can be reached. However
several important facts have emerged from these experiments.
First, our initial attempts to form complexes between Jak1 and
an isolated soluble gp130 ICD were not successful, since the
two components dissociated over gel filtration, indicating
a very low affinity interaction (data not shown). Association of
Jak1 with the full-length gp130 in detergent micelles was fars reserved
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Imaging Jak1 and Transmembrane Cytokine Receptorsmore efficient and lead to the isolation of complexes. Thus, the
membrane/lipid environment appears to be important for Jak1
association with gp130 and by extension, perhaps, other cyto-
kine receptors. Second, while Jak1 is present, it appears to exist
as a conformational ensemble in the complex, as evidenced by
the ‘‘fuzzy’’ density. We have previously shown that the gp130
intracellular domains are highly flexible, and not visible by 2D
imaging (see Figure 2) (Skiniotis et al., 2008). The Box1/Box2
sequence region of gp130, to which the Jak1 FERM domain
binds, is located at the extreme N-terminal region of the
gp130 ICD (directly after the TM), and this is where we see the
Jak1 density in the holocomplex. Presumably the uppermost
part of the density corresponds to the FERM domains, while
the density further away from the TM region of gp130 corre-
sponds to the more C-terminal domains of Jak1 that are likely
‘‘free-swinging’’ since Jak1 is only bound to gp130 via its
FERM. The nature of this single site Jak1-FERM/gp130 contact
preserves the Jak1 interdomain flexibility that is likely necessary
for the mechanism of Jak1 activation. The KD can, in principle,
associate with the FERM, and then once activated, analogous
to an unfolding scorpion’s tail, phosphorylate STAT and other
adaptors that are known to bind to the C-terminal regions of
the gp130 ICD. Unfortunately, this flexibility prevents us from
trapping the complex in a single position that will allow structural
definitions to emerge. Therefore, these studies show that while
it is indeed feasible to reconstitute the gp130 signaling holocom-
plex, future attempts will need to address the positional vari-
ability of the Jak/ICD module.
The holocomplex is greatly stabilized in nanodiscs, which
provide a surrogate membrane bilayer. Our speculation is that
the inner leaflet of the nanodisc is in contact with the Jak1
FERM domain that is bound to the Box1/Box2 near the
membrane, stabilizing the interaction. The size of the FERM
domain, coupled with the close proximity of the Box1/Box2
region to the TM segments of cytokine receptors, makes this
a plausible scenario, especially considering the fact that our re-
combinant Jaks seem to require detergent for stability. Perhaps
the FERM possesses a hydrophobic patch that is in contact
with the membrane. Future attempts to visualize the gp130/
Jak1 holocomplex will focus on cryoelectron microscopy of
nanodisc-reconstituted complex.
EXPERIMENTAL PROCEDURES
Expression and Purification of the gp130/IL-6/IL-6Ra Complex
Full-length gp130 was expressed as previously described (Skiniotis et al.,
2008). In brief, full-length, EYMPME-tagged gp130 was expressed in HiFive
cells, cell membranes were isolated and solubilized in 1% n-dodecyl-b-d-mal-
toside (DDM), and recombinant receptors were purified via an anti-Glu-Glu-
sepharose column. A soluble construct of human IL-6 fused to the D2-D3 cyto-
kine binding region of IL-6Ra (hyper IL-6) (Fischer et al., 1997) was expressed
and purified from HiFive cell supernatant via Ni-affinity and gel filtration chro-
matography. An excess of hyper-IL-6 was added to the purified gp130 and
incubated overnight. The protein mixture was then concentrated and purified
on a Superdex 200 column equilibrated in HEPES-buffered saline containing
100 mM DTT and 0.02% DDM.
Expression and Purification of Jak1
Full-length human Jak1 was cloned into the BacMam expression vector
pVLAD6 (Dukkipati et al., 2008), and recombinant baculoviruses were
prepared in SF9 insect cells. 293S cells were grown in suspension in Pro293Structure 19,media (Lonza, Inc.), infected with Jak1 baculoviruses, and protein expressed
for 24 hr at 37C. Cells were pelleted, resuspended in buffer A (20 mM Tris-
HCl [pH 8.0], 1 mM TCEP, and protease inhibitors) and dounce homogenized
to lyse the cells. Insoluble material was pelleted at45,0003 g for 1 hr at 4C,
and the supernatant harvested. To the supernatant was added 500 mM NaCl,
0.1% DDM, 20 mM imidazole, and 5% glycerol, and the lysate was incubated
with Ni-agarose affinity beads in batch for 2 hr. Beads were then collected and
washed with buffer B (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM TCEP,
0.02% DDM, 5% glycerol) containing 20 mM imidazole, followed by elution
of Jak1 from the beads in buffer B containing 200 mM imidazole. After nickel
elution, Jak1 elutions were loaded onto a Streptactin-sepharose column,
washed with buffer B, and eluted in buffer B containing 2.5 mM desthiobiotin.
Following elution from the Streptactin column, NaCl and glycerol to 500 mM
and 20% were added, respectively, in order to stabilize Jak1 in solution. Glyc-
erol was dialyzed from the Jak1 fractions immediately prior to EM imaging.
Detection of Jak1 was performed by Coomassie staining and by western
blot with an anti-Jak1 antibody (BD Biosciences 610231). The kinase activity
of purified Jak1 is described in Figure S2.Electron Microscopy
Receptor complexes and Jak1 were prepared for electron microscopy using
the conventional negative staining protocol (Ohi et al., 2004), and imaged
at room temperature with a Tecnai T12 electron microscope operated at
120 kV using low-dose procedures. Images of the hyper-IL-6/gp130 complex
were recorded on Kodak SO-163 film at a magnification of 52,0003 and a
defocus value of about –1.5 mm. Images of Jak1 and the hyper-IL-6/gp130/
Jak1 complex were recorded on imaging plates (DITABIS, Digital Biomedical
Imaging Systems AG) at a magnification of 67,0003 and a defocus value of
about –1.0 mm.Image Processing
Film recorded micrographs were digitized with a Zeiss SCAI scanner using
a step size of 7 mm, and 3 3 3 pixels were averaged to obtain a pixel size of
4.04 A˚ on the specimen level. Imaging plates were analyzed with a DITABIS
micron plate reader, and 2 3 2 pixels were averaged to obtain a pixel size of
4.48 A˚ on the specimen level.
Multireference alignment and classification for the projection analysis of all
samples was carried out using the SPIDER image processing suite (Frank
et al., 1996).
For the 2D analysis of the gp130/IL-6/IL-6Ra transmembrane complex we
interactively selected 6070 particles from 56 images taken on film. The parti-
cles were classified into 15 classes, producing consistent class averages
that showed a dominant preferred particle orientation on the carbon support
(Figure S1).
For 2D analysis and 3D reconstructions of Jak1 we interactively selected
24,356 particle pairs from 132 60/0 image pairs taken on imaging plates.
A first round of classification of the untilted specimen into 100 classes (Fig-
ure S4) revealed a substantial degree of conformational variability. As a result,
several class averages were not well defined, either revealing particles of
smaller size or particles that lacked distinct features. We thus selected the
particles belonging to the better defined classes (marked with a green dot in
Figure S4; total of 9258 particles), and subjected them to a second round of
classification into 50 classes (Figure S5). Based on this second classification
step, four independent 3D reconstructions were derived from 446 to 1050
particles belonging to single classes that revealed a range of JAK1 conforma-
tions, from fully extended (‘‘open’’) to fully compact (‘‘closed’’) (the classes
used for 3D reconstruction are marked in Figure 3D and Figure S5). In brief,
the random conical tilt technique (Radermacher et al., 1987) was used to
calculate a first back projection map using the images of the tilted specimen.
After angular refinement, the corresponding particles from the images of the
untilted specimens were added and the images were subjected to another
cycle of angular refinement. Using the resulting maps as reference models,
we calculate final 3D reconstructions with the program FREALIGN (Stewart
and Grigorieff, 2004). FREALIGN was also used for further refinement of the
orientation parameters as well as for correction of the contrast transfer func-
tion (CTF). The resolution of the final density map was 35 A˚ according to
Fourier shell correlation (FSC) using the FSC = 0.5 criterion (Figure S6).45–55, January 12, 2011 ª2011 Elsevier Ltd All rights reserved 53
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Imaging Jak1 and Transmembrane Cytokine ReceptorsFor the 2D analysis of the quarternary gp130/IL-6/IL-6Ra/Jak1 transmem-
brane complex we interactively selected 14,008 particles from 224 images
taken on imaging plates (Figure S7). After a first classification into 150 groups,
we selected 3975 particles from those classes that clearly resolved the
receptor complex ectodomain, and subjected them to a final classification
into 30 classes (Figure S8).
Molecular Modeling of Jak1
Docking, modeling, and molecular graphics for Jak1 were generated using the
UCSF Chimera package from the Resource for Biocomputing, Visualization,
and Informatics at the University of California, San Francisco (Pettersen
et al., 2004). Due to the limited resolution of our maps (35 A˚) we only
employed manual procedures to dock crystal structures into the 3D densities.
To model the kinase and pseudokinase domains we used two copies of the
atomic resolution structure of the Jak1 kinase domain (PDB ID: 3EYH)
(Williams et al., 2009). The Jak1 FERM domain was modeled using the homol-
ogous Focal Adhesion Kinase FERM domain (PDB ID: 2AL6) (Ceccarelli et al.,
2006), whereas the Jak1 SH2 domain wasmodeled using a Src tyrosine kinase
SH2 domain (PDB ID: 1IJR) (Kawahata et al., 2001).
Preparation of gp130/IL-6/IL-6Ra Nanodiscs
Nanodiscs were prepared using standard procedures essentially as described
(Ritchie et al., 2009). 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC,
Avanti Polar Lipids), dried overnight in a centrifugal evaporator, was solubilized
in 100 mM cholate (Na cholate hydrate, SIGMA) (end concentration of DPPC:
50 mM) and incubated with membrane scaffold protein MSP1 and gp130-
hyper-IL-6 complex at 37C for 15 min at end concentrations of 7 mM
(DPPC), 18 mM (cholate), 78 mM (MSP1), and 5.6 mM (gp130-hyper-IL-6
complex), respectively. Themixturewas supplementedwith 0.02% (w/v) n-do-
decyl-b-D-maltopyranoside, 0.2% (v/v) 2-mercaptoethanol, and 1mMphenyl-
methylsulfonyl fluoride (PMSF), respectively. After the incubation period at
37C, 475 mg wet Bio-Beads SM-2 (BIO-RAD), washed with methanol and
water, were added to the sample and incubated at 4C for 9 hr on a rotating
wheel to remove the detergent and initiate nanodisc self-assembly. The
sample was subsequently analyzed by gel filtration on a Superose 6 column
in 10 mM HEPES (pH 7.2), 150 mM NaCl, and 0.2% (v/v) 2-mercaptoethanol.
We observed highly efficient nanodisc formation, and the complex eluted on
gel filtration as a monodisperse peak.SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and can be found with this
article online at doi:10.1016/j.str.2010.10.010.
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